Application | Comment | Organism |
---|---|---|
drug development | pre-treatment with tissue kallikrein inhibitors and/or anti-angiogenic therapies may prove to benefit future cervical cancer patients | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytoplasm | - |
Homo sapiens | 5737 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
HeLa cell | - |
Homo sapiens | - |
HUVEC cell | - |
Homo sapiens | - |
salivary gland | duct cell | Homo sapiens | - |
submandibular gland | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
tissue kallikrein | - |
Homo sapiens |
Organism | Comment | Expression |
---|---|---|
Homo sapiens | in an endothelial-cervical carcinoma conditioned-medium model, HeLa metabolites cause a dramatic decrease in endothelial cellular tissue kallikrein and a concomitant proliferation of endothelial cells | down |
Homo sapiens | presence of tissue kallikrein in HeLa cells and in angiogenic HUVECs. In the submandibular gland control tissue, positive tissue kallikrein staining within the ductal epithelial gland. On conditioned media a dose-dependent increase of tissue kallikrein. In challenged endothelial cells with metabolites from cervical cancer cells, the reduction in cellular tissue kallikrein is associated with a concomitant increase in tissue kallikrein within the media | up |
General Information | Comment | Organism |
---|---|---|
physiological function | tumour-induced, vascular-derived tissue kallikrein that surrounds angiogenic endothelial cells likely aids in stromal remodelling to allow angiogenesis and the release of contributing co-factors, contributes to neo-vasculature invasiveness and produces a tempero-spatial chemotactic message that may be recognised by cell signaling systems | Homo sapiens |